University at Buffalo (UB)
Saby George MD
Saby George
MD
Employment:
- Associate Professor, Medicine, Roswell Park Comprehensive Cancer Center Jacobs School of Medicine & Biomedical Sciences (2017-present)
Journal Articles:
- Wood A, George S, Adra N, Chintala S, Damayanti N, Pili R. (2019) Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma. Invest New Drugs (Oct).
- Monk P, Liu G, Stadler WM, Geyer S, Huang Y, Wright J, Villalona-Calero M, Wade J, Szmulewitz R, Gupta S, Mortazavi A, Dreicer R, Pili R, Dawson N, George S, Garcia JA. (2018) Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Invest New Drugs (Oct), 36(5): 919-926.
- Pili R, Quinn DI, Hammers HJ, Monk P, George S, Dorff TB, Olencki T, Shen L, Orillion A, Lamonica D, Fragomeni RS, Szabo Z, Hutson A, Groman A, Perkins SM, Piekarz R, Carducci MA. (2017) Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870). Clin Cancer Res (Dec), 23(23): 7199-7208.
- Wentink MQ, Verheul HMW, Pal SK, George S, Voortman J, Danchaivijitr P, Adelaiye R, Poslinski D, Groman A, Hutson A, Pili R. (2017) Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma. Clin Genitourin Cancer (Jul).
- Marshall JR, Burk RF, Payne Ondracek R, Hill KE, Perloff M, Davis W, Pili R, George S, Bergan R. (2017) Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men. Oncotarget (Apr), 8(16): 26312-26322.
- Nwogu CE, Mahoney M, Okoye I, Ejiogu K, George S, Dy G, Jimoh M, Salako O, Ilegbune O, Chugani B, Ezeome E, Popoola AO, Michalek AM. (2016) Role of Private Enterprise in Cancer Control in Low to Middle Income Countries. J Cancer Epidemiol (Dec), 2016: 7121527-7121527.
- Pokharel S, Dhillon SS, Ylagan L, George S, Yendamuri S. (2016) Sclerosing Pneumocytoma with Lymph Node Metastasis. J Thorac Oncol (Jun).
- Pokuri VK, Syed JR, Yang Z, Field EP, Cyriac S, Pili R, Levine EG, Azabdaftari G, Trump DL, Guru K, George S. (2016) Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma. Clin Genitourin Cancer (Feb), 14(1): 59-65.
- Hanzly M, Aboumohamed A, Yarlagadda N, Creighton T, Digiorgio L, Fredrick A, Rao G, Mehedint D, George S, Attwood K, Kauffman E, Narashima D, Khushalani NI, Pili R, Schwaab T. (2014) High-dose interleukin-2 therapy for metastatic renal cell carcinoma: a contemporary experience. Urology (May), 83(5): 1129-1134.
- Pokuri V, Sule N, Soofi Y, Xu B, Guru K, George S. (2013) A case of unusual mast cell response with interstitial cystitis-like symptoms to neoadjuvant chemotherapy for muscle-invasive transitional cell carcinoma of the bladder. J Natl Compr Canc Netw (Dec), 11(12): 1459-1463.
- George S, Pili R. (2013) Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer. Curr Oncol Rep (Apr), 15(2): 65-68.
- George S, Pili R, Carducci MA, Kim JJ. (2011) Role of immunotherapy for renal cell cancer in 2011. J Natl Compr Canc Netw (Sep), 9(9): 1011-1018.
- Bulkley GB, Bass KN, Stephenson GR, Diener-West M, George S, Reilly PA, Baker RR, Drachman DB. (1997) Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg (Sep), 226(3): 324-334.